Xconomy Boston

Semprus BioSciences Secures $8,000,000 Series A Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=24c711d8-4ae0-4fff-a92d-af6606c063e9&Preview=1
Date
12/14/2008
Company Name
Semprus BioSciences
Mailing Address
One Kendall Street Building 1400, 1st Floor Cambridge, MA 02139
Company Description
Semprus BioSciences is a venture-backed biotechnology company developing functional surfaces to prevent medical device complications. Our initial product development efforts are focused on the first implantable and permanently antimicrobial surface technology. The intellectual property comes from the MIT labs of Prof. Robert Langer and Prof. Greg Stephanopoulos, and part of this scientific research was featured in Nature.
Website
http://www.semprusbio.com
Transaction Type
Venture Equity
Transaction Amount
$8,000,000
Transaction Round
Series A
Proceeds Purposes
The proceeds of this financing will be used to advance SEMPRUS’ product candidates.
M&A Terms
Venture Investor
5AM Ventures
Venture Investor
Pangaea Ventures